North America and Europe PEGylated Drugs Market Forecast Analysis with Key Players: Merck, Shire Group, Amgen, UCB, AstraZeneca, Sigma Tau, Pfizer, Roche, and Biogen
The North America and Europe PEGylated Drugs Market is set to exceed USD 10.5 billion by 2024
View full press release